Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Asset Utilization Ratio (2016 - 2022)

Aptevo Therapeutics (APVO) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.09 as the latest value for Q4 2022.

  • Quarterly Asset Utilization Ratio fell 53.64% to 0.09 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 0.09 through Dec 2022, down 53.64% year-over-year, with the annual reading at 0.07 for FY2022, 69.27% down from the prior year.
  • Asset Utilization Ratio hit 0.09 in Q4 2022 for Aptevo Therapeutics, down from 0.19 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.85 in Q2 2020 to a low of 0.09 in Q4 2022.
  • Historically, Asset Utilization Ratio has averaged 0.28 across 5 years, with a median of 0.22 in 2018.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 207.79% in 2020 and later plummeted 84.21% in 2021.
  • Year by year, Asset Utilization Ratio stood at 0.23 in 2018, then surged by 149.15% to 0.57 in 2019, then plummeted by 83.35% to 0.09 in 2020, then soared by 115.16% to 0.2 in 2021, then plummeted by 53.64% to 0.09 in 2022.
  • Business Quant data shows Asset Utilization Ratio for APVO at 0.09 in Q4 2022, 0.19 in Q3 2022, and 0.24 in Q2 2022.